HOME CANCER GLOSSARY  CANCER PHOTOS  NEW CANCER BOOKS  LINKING  ADVERTISE

   
 

Free Financial Help for Cancer Patients
Gov't regulated program

Breast Cancer "Switch" Found

Cancer Pictures

Best Natl Cancer Ctrs

Cancer Centers
by State


Cancer Societies

Newest Treatments
by cancer type

MyCancerNews.com

Cancer Newsletters

Medical Journals

Cancer Calculator

Nat'l Cancer Inst.

MedLine Cancer

Chemotherapy

Other helpful links

Additional Help
for Cancer Patients

More Cancer Photos

Epilepsy Epilepsy Treatment

How to Know Which Epilepsy Drug Is Right for You


Watch Video

Summary & Participants

Epilepsy drugs are important for controlling seizures. Although highly effective, they can produce various side effects. Learn which treatments are most appropriate for you.

Medically Reviewed On: July 06, 2008

Webcast Transcript


ANNOUNCER: Epilepsy, defined as the condition of chronic, recurrent, unprovoked seizures, affects approximately 3 million people in the United States. Epilepsy can be treated in a number of ways, including surgery and diet, but it’s most commonly controlled through the use of anti-seizure medications.

TRACY GLAUSER, MD: Medications have been used for the treatment of epilepsy for almost 100 years, but they’re really broken into two major groups. The most common medicines that were approved prior to 1993 include carbamazepine (also known as Tegretol), phenobarbital, phenytoin (also known as Dilantin), and valproic acid (also known as Depakote or Depakene).

Since 1993, eight new medicines have approved in the United States for the treatment of epilepsy: felbamate (also known as Felbatol), gabapentin (also known as Neurontin), lamotrigine (also known as Lamictal), levetiracetam (known as Keppra), oxcarbazepine (known as Trileptal), tiagabine (also known as Gabitril), topiramate (known as Topamax), and zonisamide (also known as Zonegran).

ANNOUNCER: Both the newer and older classes of medications seem to have similar efficacy, or ability to stop seizures. Their differences lay in their side effect profiles, with the newer medications tending to have milder side effects.

BLANCA VAZQUEZ, MD: The older antiepileptic drugs tend to have a heavier side effect profile, especially for cognition. The older drugs are associated with long-term use of and development of neuropathy, sedation, cognitive decline and mood changes. The newer antiepileptic drugs are also associated with some of those behavioral changes, but in a much milder level.

ANNOUNCER: And some side effects are related more closely to some drugs than others.

BLANCA VAZQUEZ, MD: The patients need to know what to look for or what side effects are not acceptable. For instance, the older antiepileptic drugs, like barbiturates, have a lot of sedation and mood changes. Dilantin is associated with major cognitive issues as well as bone loss and hormonal changes for female and male patients.

TRACY GLAUSER, MD: Medicines in general, such as Dilantin, can cause sedation, drowsiness, tiredness, wobbliness in walking and unsteadiness. A medicine like Dilantin can have the rare effect of causing a rash. In addition, chronic use of Dilantin can lead to changes in cosmetic features: coarsening of the facial bones, growing hair on the face, swelling of the gums. Tremor is more commonly seen in children taking valproic acid (also known as Depakote or Depakene).

Page 1 of 3 Next Page >>

 

Alternative Therapies

Melanoma Skin Cancer

Complementary and Alternative Cancer
Care Guidelines

Cancer Treatment Research Library

Dangerous Doctors
...is yours safe?

Cancer Archives

 

 

MEMBERSHIPS:     

About us
Privacy policy
Conditions of use

 


Nat'l Cervical
Cancer Coalition

logo nbtf
National Brain
Tumor
Foundation


Nat'l Ovarian
Cancer Coalition


Breast Cancer
Research

MCN
My
Cancer News

 

Special
Thanks
 TECH SUPPORT

Codebrain
Codebelly


NOTICE:  No information on this CANCER research site is provided, intended or implied to substitute for trained, professional medical advice, CANCER diagnosis or CANCER treatmentAs a condition of use of this cancer website, all visitors agree to seek trained medical advice before using any cancer treatment or cancer information found on this website and agree discuss these with their physicians prior to use and to hold RobertsReview and all entities affiliated with, contributing to, and/or operating this cancer research website harmless in regard to all information provided herein and/or from any decisions that may flow from use of this information.  RobertsReview in no way recommends, endorses or verifies the accuracy or claims of any of the cancer information provided herein by "third parties" regardless of their affiliation.

©1997-2006 RobertsReview, Wickford, RI USA. No information contained on this website may be reproduced in any form in any media.  Single copies may be reprinted for non-commercial use.